Company profile · Stockholm, Sweden

Recipharm

CDMO Operations, Sterile Manufacturing, and Pharmaceutical Supply · International CDMO manufacturing

Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint.

Lead
Greg Behar (verified ↗)
Address
Klara Ostra Kyrkogata 6, 111 52 Stockholm, Sweden (source ↗)
Compliance
GMP pharmaceutical manufacturing network
Last reviewed
14 Mar 2026 (3mo ago)
Scale
International CDMO manufacturing
Capabilities
Sterile Manufacturing · Finished Dose Production · CDMO Supply Operations
Founded
1995
Headcount
5001-10000
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Greg Behar

Chief Executive Officer

Check official leadership source
Full addressKlara Ostra Kyrkogata 6, 111 52 Stockholm, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official Recipharm Stockholm city HQ page listing the visiting address at Klara Ostra Kyrkogata 6.

Open source
Operating profile

International CDMO manufacturing

Stockholm, Sweden. CDMO Operations, Sterile Manufacturing, and Pharmaceutical Supply. Review completed on 14 Mar 2026.

2026 technical specializationCDMO Operations, Sterile Manufacturing, and Pharmaceutical Supply
Core capabilities
Sterile ManufacturingFinished Dose ProductionCDMO Supply Operations
Governance

EU and global pharmaceutical manufacturing oversight

GMP pharmaceutical manufacturing network, Quality and supply-chain operations

Editorial note

CDMO Operations, Sterile Manufacturing, and Pharmaceutical Supply

Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint.

Editorial note

Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 14 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Sterile Manufacturing
Finished Dose Production
CDMO Supply Operations
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceRecipharm official leadership page confirming Greg Behar as CEO.Source origin: recipharm.comOpen source
Supporting evidenceRecipharm official company surface describing CDMO operations.Source origin: recipharm.comOpen source
Physical-site evidenceOfficial Recipharm Stockholm city HQ page listing the visiting address at Klara Ostra Kyrkogata 6.Source origin: recipharm.comOpen source
Infrastructure

Declared infrastructure

Sterile manufacturing lines
Finished-dose production suites
Global quality systems
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
VERIFIED ACTIVE 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Recipharm located?
Recipharm operates from Klara Ostra Kyrkogata 6, 111 52 Stockholm, Sweden, Stockholm, Sweden.
Who runs Recipharm?
Recipharm is led by Greg Behar, Chief Executive Officer. Verified 14 Mar 2026.
What certifications does Recipharm hold?
Recipharm is documented under GMP pharmaceutical manufacturing network.
What does Recipharm do?
Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint. Core capabilities: Sterile Manufacturing, Finished Dose Production, CDMO Supply Operations.
Editorial context

Related technical briefs

Briefs that name Stockholm as a covered market or city.